<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01958931</url>
  </required_header>
  <id_info>
    <org_study_id>FML - 204</org_study_id>
    <nct_id>NCT01958931</nct_id>
  </id_info>
  <brief_title>Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fresh Medical Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fresh Medical Laboratories</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Study to evaluate the utility of the ProLung Test as an adjunct to CT scan in the diagnosis&#xD;
      of lung cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This Study will assess the stability of the ProLung Test classification algorithm when used&#xD;
      as an adjunct to CT scan. This Study will assess whether there are any potential safety&#xD;
      concerns of the ProLung Test when used to evaluate patients with a positive CT scan for lung&#xD;
      cancer.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ProLung Test utility in lung cancer</measure>
    <time_frame>date of conclusive diagnosis</time_frame>
    <description>This Study will assess the stability of the ProLung Test classification algorithm when used as an adjunct to CT scan to determine whether it is appropriate to be used in a pivotal study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety and Tolerability of the ProLung Test</measure>
    <time_frame>within 30 minutes of the ProLung Test</time_frame>
    <description>This Study will assess whether there are any potential safety concerns of the ProLung Test when used to evaluate patients with a positive CT scan for lung cancer.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">55</enrollment>
  <condition>Solitary Pulmonary Nodule</condition>
  <condition>Multiple Pulmonary Nodules</condition>
  <arm_group>
    <arm_group_label>Patients Suspicious for Lung Cancer</arm_group_label>
    <description>Subjects are symptomatic of lung cancer and have one or more lung nodules or lung masses suspicious for lung cancer.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with lung cancer symptoms and pulmonary lesions suspicious for lung cancer&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is male or female, age 18 or above.&#xD;
&#xD;
          -  If female, subject&#xD;
&#xD;
               -  is of non-childbearing potential meaning permanently sterile, or&#xD;
&#xD;
               -  is one year post-menopausal; or&#xD;
&#xD;
               -  is not pregnant as confirmed by negative urine pregnancy test and using adequate&#xD;
                  birth control at time of screening.&#xD;
&#xD;
          -  Subject presents with one or more of the following clinical symptoms or suspicious&#xD;
             radiological finding(s):&#xD;
&#xD;
               -  Persistent cough&#xD;
&#xD;
               -  Hoarseness&#xD;
&#xD;
               -  Shortness of breath&#xD;
&#xD;
               -  Sputum streaked with blood&#xD;
&#xD;
               -  Fatigue&#xD;
&#xD;
               -  Unexplained recent weight loss&#xD;
&#xD;
               -  Recurrent pneumonia or bronchitis&#xD;
&#xD;
               -  Chest pain&#xD;
&#xD;
               -  Abnormal chest radiograph&#xD;
&#xD;
          -  Subject has undergone a CT scan of the lungs within 44 days of measurement that&#xD;
             indicates one or more non-calcified nodules (NCN) or lung masses suspicious for lung&#xD;
             cancer.&#xD;
&#xD;
          -  Subject is capable of understanding and agreeing to fulfill the requirements of this&#xD;
             protocol.&#xD;
&#xD;
          -  Subject has signed the IRB/IEC approved informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        â€¢ Subjects who meet one or more of the following criteria may not be enrolled in this&#xD;
        Study:&#xD;
&#xD;
          -  Subject has a pacemaker or other implanted electronic device.&#xD;
&#xD;
          -  Subject with diagnosed malignancy within the past 5 (five) years except for&#xD;
             non-melanoma skin cancer.&#xD;
&#xD;
          -  Subject with significant systemic diseases including uncontrolled diabetes, severe&#xD;
             heart failure, uncontrolled hypertension, myocardial infarction and/or auto-immune&#xD;
             conditions within the prior 3 (three) months.&#xD;
&#xD;
          -  Subject taking systemic corticosteroid medication (except for inhaled) within 14 days&#xD;
             prior to measurement session.&#xD;
&#xD;
          -  Subject has had an invasive medical procedure that involves the thoracic cavity within&#xD;
             30 days prior to the measurement session.&#xD;
&#xD;
          -  Subject who currently abuses alcohol or drugs.&#xD;
&#xD;
          -  Subject presents with an anomalous physical or anatomical condition that precludes&#xD;
             measurement.&#xD;
&#xD;
          -  Subject will have undergone unusually strenuous exercise within 24 hours prior to&#xD;
             measurement session.&#xD;
&#xD;
          -  Subject who has, in the Principal Investigator's opinion, any medical condition or&#xD;
             other circumstance that would prevent completion of this Study or interfere with&#xD;
             analysis of the Study results.&#xD;
&#xD;
          -  Subjects who have undergone radiation and chemotherapy treatment within the past 30&#xD;
             days.&#xD;
&#xD;
          -  Subject receiving therapy for documented or suspected chest infection.&#xD;
&#xD;
          -  Pregnant or lactating females.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johns Hopkins School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <study_first_submitted>October 7, 2013</study_first_submitted>
  <study_first_submitted_qc>October 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2013</study_first_posted>
  <last_update_submitted>October 8, 2013</last_update_submitted>
  <last_update_submitted_qc>October 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Pulmonary Nodules</mesh_term>
    <mesh_term>Solitary Pulmonary Nodule</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

